Quantcast

Ceres Ventures, Inc. Announces Plans to Accelerate Commercialization of its Proprietary BluFlow™ Water Treatment Technology

July 16, 2012

Company announces plans to accelerate commercialization of first-of-its-kind water purification solution that incorporates the Company´s proprietary, patent-pending nanotechnology and advanced ultra-purification technology to economically produce clean water.

New York, NY (PRWEB) July 16, 2012

Ceres Ventures, Inc. (OTCQB: CEVE) (the “Company”), a development stage company currently engaged in identifying, acquiring and developing a comprehensive portfolio of technologies relating to clean resources technologies, announced today plans to advance its efforts to commercialize the Company´s novel advanced water and wastewater purification and treatment system (the “BluFlow Water Treatment System”), a first-of-its-kind water purification solution that incorporates the Company´s proprietary, patent-pending nanotechnology and advanced ultra-purification technology to economically produce clean water.

While conventional water, wastewater, and gray water treatment technologies utilize multiple systems and reverse osmosis processes to treat or recover water, only approximately 60% of the water that flows through the treatment systems and reverse osmosis processes is recovered for reuse. In addition, many of these processes tend to have associated high energy, operations and maintenance costs. The BluFlow Water Treatment System is a unique single integrated system that simultaneously removes specific targeted chemicals/pollutants or valuable elements or compounds at very high efficiencies from contaminated water while purifying up to 95% of treated water while incurring lower energy, operating and maintenance costs, when compared to conventional water treatment systems.

The Company´s patent pending BluFlow Water Treatment System features customizable nanoparticles specifically formulated to target and remove specific contaminates, pollutants, or valuable elements or compounds based upon the attributes of the water being treated. Unlike conventional wastewater treatment technologies that simply reduce the concentration of contaminants in water, the specialized nanoparticles used by the BluFlow Water Treatment System allow the system to target and remove specific elements or compounds from the water.

The BluFlow Water Treatment System provides industrial water users with a cost-effective solution to treat water while minimizing the use of freshwater resources in the industrial process. Its unique capability to target and remove specific valuable elements and compounds while lowering energy costs, water usage, maintenance costs, and downtime translates into lower production costs and higher profit margins for producers of natural chemicals for food, cosmetics, toiletries, and pharmaceuticals. Moreover, in the United States 75% of the electricity generated is produced by thermoelectric power plants that use 201 billion gallons of water that is withdrawn daily for cooling purposes from our rivers, lakes, stream, and aquifers. For these power plants, the BluFlow Water Treatment System provides substantial energy savings and cost savings while reducing the freshwater usage impact on the environment.

“The BluFlow Water Treatment System is an extraordinary treatment and purification system that can be utilized on a cross-platform basis and provides an opportunity for significant environmental, operational, and economic benefits to its end users,” explained Meetesh Patel, the Company´s President and Chief Executive Officer.

“In the upcoming months, we anticipate taking significant efforts to accelerate the development and eventual commercialization of our BluFlow Water Treatment System. Our priorities include obtaining additional financing to accelerate our commercialization efforts, the development of additional patent protection, improved manufacturability, completion of feasibility studies for performance and field testing evaluation, and the acquisition of strategic management-level talent to help advance our technology from research and development to the commercial market,” concluded Mr. Patel.

Specific initiatives related to the development of the BluFlow Water Treatment System that are planned to take place in the upcoming months include:

  •     Bolstering commercial protection with additional patent filings;
  •     Scaling up current working prototype;
  •     Developing low cost manufacturing methods;
  •     Completing a field ready second generation prototype of the BluFlow Water Treatment System;
  •     Identifying and collaborating with nationally recognized engineering firms to initiate field testing and pre-sales activities;
  •     Manufacturing and installing initial BluFlow Water Treatment Systems for market validation and field testing; and
  •     Pursuing commercial partnership opportunities.

About Ceres Ventures, Inc.

Ceres Ventures, Inc., together with its wholly owned subsidiaries is a developer of next generation clean technologies for the remediation and purification of water, air, and soil.

Over time, the Company seeks to actively deliver environmental remediation systems and services to address the water, air and soil markets. Based on the essential nature of water, the Company´s initial focus is on the water market.

For additional information, please visit:http://www.ceresventures.com

To receive future press releases via email, please visit:

http://www.ceresventures.com/contact

To view the full HTML text of this release, please visit:

http://www.ceresventures.com/ceres-ventures-announces-plans-to-accelerate-commercialization-efforts/

Legal Notice Regarding Forward-Looking Statements

No statement herein should be considered an offer or a solicitation of an offer for the purchase or sale of any securities. This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although Ceres Ventures, Inc. (the “Company” or Ceres Ventures”) believes that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, it can give no assurance that such expectations and assumptions will prove to have been correct. Forward-looking statements, which involve assumptions and describe our future plans, strategies, and expectations, are generally identifiable by use of the words “may,” “will,” “should,” “could,” “expect,” “anticipate,” “estimate,” “believe,” “intend,” or “project” or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including but not limited to adverse economic conditions, intense competition, lack of meaningful research results, entry of new competitors and products, adverse federal, state and local government regulation, inadequate capital, unexpected costs and operating deficits, increases in general and administrative costs, termination of contracts or agreements, technological obsolescence of the Company’s products, technical problems with the Company’s research and products, price increases for supplies and components, litigation and administrative proceedings involving the Company, the possible acquisition of new businesses or technologies that result in operating losses or that do not perform as anticipated, unanticipated losses, the possible fluctuation and volatility of the Company’s operating results, financial condition and stock price, losses incurred in litigating and settling cases, dilution in the Company’s ownership of its business, adverse publicity and news coverage, inability to carry out research, development and commercialization plans, loss or retirement of key executives and research scientists, changes in interest rates, inflationary factors, and other specific risks. There can be no assurance that further research and development will validate and support the results of our preliminary research and studies. Further, there can be no assurance that the necessary regulatory approvals will be obtained or that Ceres Ventures will be able to develop commercially viable products on the basis of its technologies. In addition, other factors that could cause actual results to differ materially are discussed in the Company’s most recent Form 10-Q and Form 10-K filings with the Securities and Exchange Commission. These reports and filings may be inspected and copied at the Public Reference Room maintained by the U.S. Securities & Exchange Commission at 100 F Street, N.E., Washington, D.C. 20549. You can obtain information about operation of the Public Reference Room by calling the U.S. Securities & Exchange Commission at 1-800-SEC-0330. The U.S. Securities & Exchange Commission also maintains an Internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the U.S. Securities & Exchange Commission at http://www.sec.gov. The Company undertakes no obligation to publicly release the results of any revisions to these forward looking statements that may be made to reflect the events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/7/prweb9698548.htm


Source: prweb



comments powered by Disqus